Search

Author/Creator Fiore, Joseph

1. A Case of Hepatic Portal Venous Gas: Hypothesis of a Transient Direct Communication between a Penetrating Antral Gastric Ulcer and Mesenteric Varices. (26th February 2017)

Authors:
Ghoz, Hassan M.; Sheikh, Shamlan M.; Khandelwal, Kanika; Fiore, Joseph; James, Nicholas; Weinstock, Joel
Other Names:
Moriwaki Yoshihiro Academic Editor.
Journal:
Case reports in gastrointestinal medicine
Issue:
Volume 2017(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study. Issue 11 (November 2016)

Authors:
Langer, Corey J; Gadgeel, Shirish M; Borghaei, Hossein; Papadimitrakopoulou, Vassiliki A; Patnaik, Amita; Powell, Steven F; Gentzler, Ryan D; Martins, Renato G; Stevenson, James P; Jalal, Shadia I; Panwalkar, Amit; Yang, James Chih-Hsin; Gubens, Matthew; Sequist, Lecia V; Awad, Mark M; Fiore, Jos...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 11(2016:Nov.)
Page Start:
1497
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817. Issue 2 (1st February 2023)

Authors:
Ready, Neal E; Audigier-Valette, Clarisse; Goldman, Jonathan W; Felip, Enriqueta; Ciuleanu, Tudor-Eliade; Rosario García Campelo, María; Jao, Kevin; Barlesi, Fabrice; Bordenave, Stéphanie; Rijavec, Erika; Urban, Laszlo; Aucoin, Jean-Sébastien; Zannori, Cristina; Vermaelen, Karim; Arén Frontera, O...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 2(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non–small-cell lung cancer: KEYNOTE-021 cohorts D and H. (April 2019)

Authors:
Gubens, Matthew A.; Sequist, Lecia V.; Stevenson, James P.; Powell, Steven F.; Villaruz, Liza C.; Gadgeel, Shirish M.; Langer, Corey J.; Patnaik, Amita; Borghaei, Hossein; Jalal, Shadia I.; Fiore, Joseph; Saraf, Sanatan; Raftopoulos, Harry; Gandhi, Leena
Journal:
Lung cancer
Issue:
Volume 130(2019)
Page Start:
59
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗